TP63作为TP53突变质母细胞瘤中铁亡的调节剂
Haiping Cai1, Jiahao Yang2, Feifei Luo3
1Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. caihaiping@gdph.org.cn.
Cell death & disease
|August 12, 2025
概括
质母细胞瘤 (GBM) 中的TP53突变促进对细胞死亡途径铁亡的抗性. 这通过Wnt/β-catenin-TP63-GPX4轴发生,为这种侵略性脑瘤提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡研究 细胞死亡研究
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良结果的侵袭性脑瘤.
- 铁,一种依赖于铁的细胞死亡,是潜在的GBM脆弱性.
- 在GBM中调节铁亡的机制,特别是关于遗传突变的机制,尚未完全理解.
研究的目的:
- 调查TP53突变对GBM中铁灭症敏感性的影响.
- 在TP53突变的背景下,确定铁亡的关键调节者.
- 阐明将TP53突变与铁灭性耐药性联系起来的分子途径.
主要方法:
- 对GBM患者数据 (TCGA) 的综合性转录和突变分析.
- 功能性实验评估铁灭敏感性,活性氧物种 (ROS) 和脂质过氧化.
- 涉及信号通路分析 (Wnt/β-catenin) 和基因表达 (TP63,GPX4) 的机制研究.
主要成果:
- TP53突变与不良的GBM预后和改变的铁/谷氨酸代谢基因表达相关.
- TP63,特别是ΔNp63异型,在TP53-突变的GBM中受到上调.
- 通过减少ROS和脂质过氧化,TP63抑制铁.
- TP53突变激活了Wnt/β-catenin信号传递,对TP63进行了上调,这反过来又增强了GPX4的表达,抑制了ferroptosis.
结论:
- 一个新的信号轴 (TP53突变-Wnt/β-catenin-TP63-GPX4) 赋予了GBM的铁性耐药性.
- 这一途径代表了质母细胞瘤中铁亡调节的关键机制.
- 了解这一轴,可以深入了解潜在的治疗策略,以向GBM中的ferroptosis.
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K